학술논문

ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy
Document Type
Article
Source
In: Frontiers in Oncology. (Frontiers in Oncology, 3 April 2020, 10)
Subject
Language
English
ISSN
2234943X